NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
3.730
-0.490 (-11.61%)
At close: Sep 5, 2025, 4:00 PM
3.690
-0.040 (-1.07%)
After-hours: Sep 5, 2025, 8:00 PM EDT
NovaBay Pharmaceuticals Employees
As of December 31, 2024, NovaBay Pharmaceuticals had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees decreased by 12 or -46.15% compared to the previous year.
Employees
14
Change (1Y)
-12
Growth (1Y)
-46.15%
Revenue / Employee
$698,643
Profits / Employee
$165,643
Market Cap
21.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 14 | -12 | -46.15% |
| Dec 31, 2023 | 26 | -7 | -21.21% |
| Dec 31, 2022 | 33 | 2 | 6.45% |
| Dec 31, 2021 | 31 | 6 | 24.00% |
| Dec 31, 2020 | 25 | -3 | -10.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NBY News
- 11 days ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 18 days ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 6 months ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire
- 8 months ago - NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire
- 9 months ago - NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - Business Wire
- 9 months ago - NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - Business Wire
- 10 months ago - NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024 - Business Wire
- 10 months ago - Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand - Business Wire